Literature DB >> 21351447

[Paeoniflorin increases beta-defensin expression and attenuates lesion in the colonic mucosa from mice with oxazolone-induced colitis].

Yi Zhou1, He Wang, Yue-Shan Li, Yi-Wen Tao, Jian-Ye Zhang, Zhi-Qiang Zhang.   

Abstract

Previous studies have demonstrated that the Chinese medicine paeoniflorin, derived from the Ranunculaceae plant peony, peony, purple peony root, was able to have anti-inflammatory, anti-ulcer, anti-hypersusceptibility and anti-oxidation activity. In order to elucidate the pesticide effect and the mechanisms by which paeoniflorin exerts its effect of anti-inflammation and immunoregulation on oxazolone-induced colitic mice, disease activity index (DAI) and histological grading of colitis (HGC) were evaluated in animal model. Moreover, the expressions of HBD-2, IL-6 and IL-10 of mice with experimental colitis were observed with immunohistochemistry and RT-PCR in this study. Results showed that DAI and HGC of oxazolone control group was significantly higher than that of normal control group, and that paeoniflorin groups and 5-ASA group, compared with oxazolone control group, could alleviate the symptoms and histological damages of colitic mice (P < 0.05, P < 0.01). The expression of HBD-2 and IL-6 cytokine on the colon of colitic mice was higher than that of normal control, paeoniflorin and 5-ASA groups (P < 0.05, P < 0.01), but the expression of IL-10 is lower than that of normal control, paeoniflorin and 5-ASA groups (P < 0.05, P < 0.01). The positive correlations were demonstrated between the expression of (HBD-2 and IL-6) and DAI (Pearson r = 0.728, Pearson r = 0.758, P < 0.01, respectively), (HBD-2 and IL-6) and HGC (Pearson r = 0.819, Pearson r = 0.825, P < 0.01, respectively), whereas, the negative correlations were demonstrated between the expression of IL-10 and DAI (Pearson r = -0.789, P < 0.01), IL-10 and HGC (Pearson r = -0.725, P < 0.01). It can be concluded that to some extent paeoniflorin effectively alleviate the symptoms of oxazolone-induced colitis through regulating the expression of HBD-2, IL-6 and IL-10.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21351447

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  4 in total

1.  Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.

Authors:  Jingjing Zhang; Wei Dou; Eryun Zhang; Aning Sun; Lili Ding; Xiaohui Wei; Guixin Chou; Sridhar Mani; Zhengtao Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-14       Impact factor: 4.052

2.  Paeoniflorin upregulates β-defensin-2 expression in human bronchial epithelial cell through the p38 MAPK, ERK, and NF-κB signaling pathways.

Authors:  Yuying Gan; Xuefan Cui; Ting Ma; Yanliang Liu; Amin Li; Mao Huang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 3.  Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease.

Authors:  Wenbin Dai; Longhai Long; Xiaoqiang Wang; Sen Li; Houping Xu
Journal:  Chin Med       Date:  2022-04-28       Impact factor: 4.546

4.  Dehydroandrographolide enhances innate immunity of intestinal tract through up-regulation the expression of hBD-2.

Authors:  Wen-Bi Xiong; Zhen-Jun Shao; Yao Xiong; Jian Chen; Yun Sun; Ling Zhu; Li-Ming Zhou
Journal:  Daru       Date:  2015-07-30       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.